Hemodynamic Optimization: Measuring Cardiac Index During CRS and HIPEC

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a complex, high-stakes oncological procedure used to treat peritoneal surface malignancies. Because this surgery involves extensive abdominal dissection and significant physiological stress, hemodynamic monitoring is paramount. Among the various parameters used to guide fluid and vasopressor therapy, the Cardiac Index (CI) has emerged as a critical metric for ensuring adequate tissue perfusion.

The Physiological Challenge of CRS/HIPEC

Patients undergoing CRS/HIPEC face a "double hit" to their hemodynamic stability. The surgical component involves massive fluid shifts, blood loss, and prolonged anesthesia. Subsequently, the HIPEC phase introduces profound physiological changes, including systemic hyperthermia, vasodilation, and the absorption of cytotoxic agents. These factors increase metabolic demand while simultaneously challenging the cardiovascular system's ability to maintain systemic vascular resistance and cardiac output.

Maintaining an adequate Cardiac Indexthe cardiac output normalized to the patients body surface areais essential. If the CI drops, it indicates inadequate oxygen delivery to the vital organs, which can lead to postoperative complications such as acute kidney injury, poor wound healing, and anastomotic leakage.

Defining and Measuring Cardiac Index

Cardiac Index is defined as the Cardiac Output (CO) divided by the Body Surface Area (BSA). It provides a more accurate representation of heart performance across patients of different sizes. In the operating room, clinicians utilize several methods to measure this in real-time:

• Pulse Contour Analysis: Using arterial line waveforms to estimate stroke volume and cardiac output. This is the most common minimally invasive approach used during CRS/HIPEC.
• Esophageal Doppler Monitoring: Measures blood flow velocity in the descending aorta to calculate cardiac output. It is highly sensitive to changes in preload but can be affected by the positioning of the probe.
• Transesophageal Echocardiography (TEE): Provides direct visualization of cardiac contractility and volume status. While gold-standard for structural assessment, it is more resource-intensive.
• Pulmonary Artery Catheter (PAC): Historically the gold standard, it provides direct thermodilution measurements. However, its use has declined in favor of less invasive methods due to the associated risks of catheter placement.

The Role of CI in Goal-Directed Fluid Therapy (GDFT)

During the CRS phase, the goal of monitoring is to maintain a "steady state" of fluid balance. Excessive fluid administration can cause tissue edema, hindering surgical visualization and recovery, while fluid deficit risks hypoperfusion. By utilizing CI monitoring, anesthesiologists can implement Goal-Directed Fluid Therapy (GDFT).

GDFT moves away from arbitrary fluid boluses toward evidence-based adjustments. By observing how the Cardiac Index responds to a fluid challenge, the clinician can determine if the patient is "fluid-responsive"meaning the heart is operating on the ascending limb of the Frank-Starling curve. If the CI increases significantly with a bolus, the patient remains fluid-responsive and will benefit from further volume. If the CI plateaus, further fluid administration may cause pulmonary edema without improving perfusion.

Hemodynamic Shifts During HIPEC

The introduction of the heated chemotherapy solution changes the hemodynamic landscape significantly. The increased core temperature leads to systemic vasodilation, often necessitating the use of vasopressors to maintain mean arterial pressure (MAP). However, managing MAP alone can be misleading; a patient may have a normal MAP but a low Cardiac Index due to excessive vasoconstriction or impaired contractility. Therefore, monitoring CI allows the clinical team to balance vasopressor use with volume expansion, ensuring that the elevated metabolic rate induced by hyperthermia is met with sufficient oxygen delivery.

Conclusion

Measuring the Cardiac Index during CRS and HIPEC is not merely a monitoring task; it is a vital component of the surgical safety strategy. By integrating precise hemodynamic monitoring into the anesthesia protocol, clinicians can navigate the volatile physiological changes inherent in this extensive procedure. Ultimately, maintaining an optimal Cardiac Index reduces the risk of organ dysfunction and promotes a more favorable recovery trajectory for patients undergoing this life-saving treatment.